financetom
Business
financetom
/
Business
/
US FDA approves Vanda's drug for bipolar disorder
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
US FDA approves Vanda's drug for bipolar disorder
Apr 2, 2024 3:22 PM

April 2 (Reuters) - The U.S. FDA approved Vanda

Pharmaceuticals' ( VNDA ) drug to treat manic and mixed episodes

associated with a type of bipolar disorder, the company said on

Tuesday, marking the second approval for the treatment.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
EXPLAINER-What is aircraft turbulence and how common is it?
EXPLAINER-What is aircraft turbulence and how common is it?
May 21, 2024
May 21 (Reuters) - One passenger died of a suspected heart attack and 30 others were injured after a Singapore Airlines flight from London to Singapore hit severe turbulence on Tuesday, forcing the Boeing 777-300ER jet to divert to Bangkok, authorities said. WHAT IS TURBULENCE? Turbulence or pockets of disturbed air can have many causes, most obviously the unstable weather...
Walt Disney Unusual Options Activity
Walt Disney Unusual Options Activity
May 21, 2024
Whales with a lot of money to spend have taken a noticeably bullish stance on Walt Disney ( DIS ). Looking at options history for Walt Disney ( DIS ) we detected 27 trades. If we consider the specifics of each trade, it is accurate to state that 40% of the investors opened trades with bullish expectations and 37% with...
Top Midday Decliners
Top Midday Decliners
May 21, 2024
02:11 PM EDT, 05/21/2024 (MT Newswires) -- GT Biopharma ( GTBP ) said Tuesday it priced a registered direct offering of 740,000 shares at $4.35 per share to raise about $3.2 million for general corporate purposes. It will also issue warrants in a concurrent private placement. Shares sank about 31%, with intraday trading volume at more than 18.1 million versus...
Kraken Robotics Completes $20.1 Million Bought-Deal Financing
Kraken Robotics Completes $20.1 Million Bought-Deal Financing
May 21, 2024
02:12 PM EDT, 05/21/2024 (MT Newswires) -- Kraken Robotics ( KRKNF ) on Tuesday said it closed a bought-deal share offering that raised $20.1 million. The company sold an underwriting syndicate 21.19-million shares priced at $0.95 each, including the full exercise of the over-allotment option. Net proceeds will be used to fund Kraken's long term strategy, strengthen its balance sheet...
Copyright 2023-2026 - www.financetom.com All Rights Reserved